Investors

Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health Plc has now been registered at Companies House and is therefore effective.

Trading in the Company's shares on AIM under the new name of OptiBiotix Health Plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com

 

For further information, please contact:

Ducat Ventures plc Adam Reynolds, Executive Chairman	www.ducatventures.co.uk Contact via Walbrook below
Cairn Financial Advisers LLP Liam Murray / Avi Robinson	+44 (0)20 7148 7900
Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey	Tel: 020 7469 0936
Walbrook PR Ltd	Tel: 020 7933 8780 or [email protected]
Paul McManus Anna Dunphy	Mob: 07980 541 893 Mob: 07876 741 001